Ischemic heart disease in women may not show up on standard tests
Ischemic heart disease in women can lead to a heart attack, but this risk may go unnoticed. This is because a patient’s diagnostic coronary angiogram shows “clear” arteries. “When diagnosing women for ischemic heart disease, [...]
View moreBorderline hypertension poses myocardial dysfunction risks
Borderline hypertension or subclinical hypertension is a substrate for myocardial dysfunction, and patients can go for a long time with hypertension that isn’t clinically recognized, according to a heart failure specialist at Norton Heart & […]
View morePaul A. Tennant, M.D., joins Norton Cancer Institute
Paul A. Tennant, M.D., has joined Norton Cancer Institute as a head and neck surgical oncologist. He treats complex benign and malignant conditions of the head and neck. Dr. Tennant sees patients at Norton Cancer […]
View moreHypertension in women and its consequences
The risks and consequences of hypertension in women differ from those in men and change throughout women’s lifetimes. Overall, hypertension in women is less prevalent than in men until age 60 and becomes more prevalent […]
View moreApril 2023 Norton Medical Group New Providers
George Gad, M.D. Hospital Medicine Uchenna L. Ozor, M.D. Hospital Medicine Taylor D. Burkhardt, APRN Medical Oncology Jacqueline M. Caffrey, APRN Cardiology Erin Semeyn, APRN Medical Oncology
View moreApril 2023 Norton Children’s Medical Group New Providers
Caroline N. Jackson, M.D. Neonatology Bethanie N. Morgan, M.D. Pediatric Neurology Adrian R. O’Hagan, M.D. Pediatric Pulmonology Shelbye M. Schweinhart, M.D. Neonatology Ryne B. Bruner, APRN Pediatric Behavioral Health Jasmine L. Grier, […]
View moreKeeping up with treatment and exams can postpone an MS relapse
Monitoring multiple sclerosis (MS) for treatment options through regular visits to an MS specialist can postpone relapses and improve quality of life. “MS is a complicated disease that affects each patient differently. By seeing patients [...]
View moreGilteritinib and venetoclax regimen yields encouraging results against FLT3-mutated AML
A new regimen of FMS-related tyrosine kinase 3 (FLT3) inhibitor gilteritinib and venetoclax was tolerable at standard doses and produced high response rates for advanced, FLT3-mutated acute myeloid leukemia (AML) in a multicenter Phase 1 [...]
View moreReferral guide for Norton Louisville Arm & Hand
Referrals to Norton Louisville Arm & Hand typically can be seen by the next day, if necessary, for both simple and complex conditions, including fractures — from the humerus to the fingertip. Some of the [...]
View moreHigher precision in deep brain stimulation for Parkinson’s disease
The patient A 63-year-old woman was diagnosed with Parkinson’s disease eight years earlier, after developing stiffness of the right arm and leg while undergoing treatment for breast cancer. She then developed tremor of the right [...]
View moreNorton Heart & Vascular Institute expands Women’s Heart Program
Norton Heart & Vascular Institute launched a Women’s Heart Program in 1995. Today it has expanded to include more providers and services for a region where heart disease, especially in women, is a deadly issue. [...]
View moreChildren with fractures heal faster, so cast time should be limited
Forearm fractures, one of the most common pediatric fractures, can be safely and effectively treated with cast immobilization. Younger children heal faster, so the time in a cast should be limited to four to six [...]
View more